Prasugrel
Overview
Prasugrel is an oral antiplatelet medication that is used to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome. It works by inhibiting platelet aggregation through the irreversible antagonism of the P2Y12 platelet ADP-receptor.
API suppliers (8)
Suppliers of Prasugrel evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 4 of 8 suppliers.
4 of 8 hold a GMP certificate on record in the EU or UK registers
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
- RUYUAN HEC PHARM CO LTD1 active DMF
- LUPIN MANUFACTURING SOLUTIONS LTD1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
- ZAKLADY FARMACEUTYCZNE POLPHARMA SA
Therapeutic areas
Do you supply Prasugrel? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.